"CHINESE COASTER" - 2: AT THE TURN OF 2023-2024

被引:0
|
作者
Mikheev, Vasily V. [1 ]
Lukonin, Sergei A. [1 ]
机构
[1] Russian Acad Sci, Primakov Natl Res Inst World Econ & Int Relat, IMEMO, 23 Profsoyuznaya Str, Moscow 117997, Russia
来源
关键词
China; foreign policy; domestic policy; economy;
D O I
10.20542/0131-2227-2024-68-7-68-78
中图分类号
D81 [国际关系];
学科分类号
030207 ;
摘要
The most important event in the China-U.S. relations at the end of 2023 was the meeting of Xi Jinping and J. Biden in San Francisco on the sidelines of the APEC Summit in November 2023. The meeting did not become a breakthrough in relations between the two countries, but it created the foundations for establishing cooperation in mutually beneficial areas. Agreements were reached on the restoration of military contacts, the resumption of activities of working groups on economic and financial cooperation, the development of cooperation in the fields of artificial intelligence, green economy, climate change, etc. At the same time, many economic and political issues remained unresolved: American trade and economic sanctions against China, and, most importantly, disagreements over Taiwan. Against the background of the China-U.S. Summit, Beijing policy has strengthened its two-vector nature. Before the Summit in the United States, a Sino-Russian Summit was held in Beijing in October 2023. Later, in December 2023, the China-EU Summit took place. Their results are contradictory. Xi described Sino-Russian relations as "healthy and stable". The Summit with the EU ended almost to no avail. An important foreign policy move made by Beijing was the Belt and Road Summit of October 2023, at which Chinese plans to institutionalize this strategy were announced, including the creation of the Belt and Road secretariat and "other institutions", supported with 100 bln U.S. dollars injections. In domestic politics, Xi's authoritarianism continued to strengthen, accompanied by restrictions on the freedom of speech. In the economy, China kept the GDP growth rate for 2023 in the desired range from 5 to 5.5%. The main task for Beijing in the field of economics for 2024 is at least to keep the growth rate of the national GDP at about 5%.
引用
收藏
页数:140
相关论文
共 50 条
  • [1] Influenza Vaccine for 2023-2024
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1687): : 161 - 166
  • [2] State of Wildfires 2023-2024
    Jones, Matthew W.
    Kelley, Douglas I.
    Burton, Chantelle A.
    Di Giuseppe, Francesca
    Barbosa, Maria Lucia F.
    Brambleby, Esther
    Hartley, Andrew J.
    Lombardi, Anna
    Mataveli, Guilherme
    McNorton, Joe R.
    Spuler, Fiona R.
    Wessel, Jakob B.
    Abatzoglou, John T.
    Anderson, Liana O.
    Andela, Niels
    Archibald, Sally
    Armenteras, Dolors
    Burke, Eleanor
    Carmenta, Rachel
    Chuvieco, Emilio
    Clarke, Hamish
    Doerr, Stefan H.
    Fernandes, Paulo M.
    Giglio, Louis
    Hamilton, Douglas S.
    Hantson, Stijn
    Harris, Sarah
    Jain, Piyush
    Kolden, Crystal A.
    Kurvits, Tiina
    Lampe, Seppe
    Meier, Sarah
    New, Stacey
    Parrington, Mark
    Perron, Morgane M. G.
    Qu, Yuquan
    Ribeiro, Natasha S.
    Saharjo, Bambang H.
    San-Miguel-Ayanz, Jesus
    Shuman, Jacquelyn K.
    Tanpipat, Veerachai
    van der Werf, Guido R.
    Veraverbeke, Sander
    Xanthopoulos, Gavriil
    EARTH SYSTEM SCIENCE DATA, 2024, 16 (08) : 3601 - 3685
  • [3] The Dead Fly, 2023-2024
    Creten, Johan
    CONNAISSANCE DES ARTS, 2024, (838): : 106 - 106
  • [4] AAG COUNCILLORS FOR 2023-2024
    Baensch, Aaron
    Lett, Ray
    Morris, Paul
    Noble, Ryan
    van Geffen, Pim
    ELEMENTS, 2023, 19 (02) : 118 - 118
  • [5] 2 The work of the British School at Athens, 2023-2024
    Sweetman, Rebecca
    ARCHAEOLOGICAL REPORTS, 2024, 70 : 11 - 42
  • [6] Graduate Medical Education, 2023-2024
    Andrews, John S.
    Mathews, Chris
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [7] Farmer Protests in Europe 2023-2024
    Finger, Robert
    Fabry, Anna
    Kammer, Marie
    Candel, Jeroen
    Dalhaus, Tobias
    Meemken, Eva Marie
    EUROCHOICES, 2024, 23 (03) : 59 - 63
  • [8] Polypharmacology: new drugs in 2023-2024
    Ryszkiewicz, Piotr
    Malinowska, Barbara
    Schlicker, Eberhard
    PHARMACOLOGICAL REPORTS, 2025,
  • [9] Antiviral Drugs for Influenza for 2023-2024
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1689): : 177 - 182
  • [10] Robocup 2023-2024 ROSbag Dataset
    Fernandez, Irene Gonzalez
    Narvaez, Juan Diego Pena
    Hernandez, Jose Miguel Guerrero
    Rodriguez, Rodrigo Perez
    Canton, Alejandro Gonzalez
    Lera, Francisco Javier Rodriguez
    DATA IN BRIEF, 2024, 57